Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ayala Pharmaceuticals Inc (AYLA)

Ayala Pharmaceuticals Inc (AYLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,464
  • Shares Outstanding, K 14,821
  • Annual Sales, $ 3,510 K
  • Annual Income, $ -40,250 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.98
  • Price/Sales 4.45
  • Price/Cash Flow N/A
  • Price/Book 0.91
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.52
  • Most Recent Earnings $-0.66 on 11/04/22
  • Next Earnings Date 11/21/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.75
  • Number of Estimates 1
  • High Estimate -0.75
  • Low Estimate -0.75
  • Prior Year -0.66
  • Growth Rate Est. (year over year) -13.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3568 +41.14%
on 01/03/23
0.5906 -14.73%
on 01/10/23
+0.0034 (+0.68%)
since 12/16/22
3-Month
0.3568 +41.14%
on 01/03/23
0.9611 -47.60%
on 10/19/22
-0.4079 (-44.75%)
since 10/18/22
52-Week
0.3568 +41.14%
on 01/03/23
7.3100 -93.11%
on 01/19/22
-6.3364 (-92.64%)
since 01/18/22

Most Recent Stories

More News
Ayala Pharmaceuticals: Fiscal Q4 Earnings Snapshot

Ayala Pharmaceuticals: Fiscal Q4 Earnings Snapshot

AYLA : 0.5036 (+5.84%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IAA, POSH, AYLA, AGFS

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

IAA : 39.89 (-0.10%)
POSH : 17.90 (unch)
AYLA : 0.5036 (+5.84%)
AGFS : 3.00 (+0.33%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FORG, AYLA, SPNE, OFIX

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

FORG : 23.21 (+6.08%)
AYLA : 0.5036 (+5.84%)
SPNE : 9.54 (+8.29%)
OFIX : 17.93 (-0.44%)
AYLA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Ayala Pharmaceuticals, Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) and Advaxis, Inc. is fair to Ayala shareholders. Upon completion of the...

AYLA : 0.5036 (+5.84%)
Q2 Financial Results Send Micro Cap Soaring

A small %Biotech company saw its shares trading higher during Tuesday’s session after the company announced its second quarter financial results for 2022. Some financial highlights from the press release...

AYLA : 0.5036 (+5.84%)
Ayala Pharmaceuticals Announces Interim Data from Part A of the Phase 2/3 RINGSIDE Trial of AL102 in Desmoid Tumors

- Tumor shrinking observed in substantially all patients who were evaluable at 16 weeks - - Favorable safety results observed: AL102 was well tolerated...

AYLA : 0.5036 (+5.84%)
Ayala Pharmaceuticals to Present at the 2022 Jefferies Global Healthcare Conference

REHOVOT, Israel and WILMINGTON, Del., June 02, 2022 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA), a clinical-stage oncology company...

AYLA : 0.5036 (+5.84%)
Ayala Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

Interim data from Part A of RINGSIDE study of AL102 expected mid-2022...

AYLA : 0.5036 (+5.84%)
Ayala Pharmaceuticals Announces Poster Presentation on AL101 at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

REHOVOT, Israel and WILMINGTON, Del., April 27, 2022 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA), a clinical-stage oncology company...

AYLA : 0.5036 (+5.84%)
Ayala Pharmaceuticals Reports Full-Year 2021 Financial Results and Provides Corporate Update

- Part A of AL102 RINGSIDE study fully enrolled; interim data expected mid-2022 –...

AYLA : 0.5036 (+5.84%)

Business Summary

Ayala Pharmaceuticals Inc. is a clinical-stage oncology company. It focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. Ayala Pharmaceuticals Inc. is based in Rehovot, Israel.

See More

Key Turning Points

3rd Resistance Point 0.6989
2nd Resistance Point 0.6343
1st Resistance Point 0.5690
Last Price 0.5036
1st Support Level 0.4391
2nd Support Level 0.3745
3rd Support Level 0.3092

See More

52-Week High 7.3100
Fibonacci 61.8% 4.6539
Fibonacci 50% 3.8334
Fibonacci 38.2% 3.0129
Last Price 0.5036
52-Week Low 0.3568

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar